NCT07280377
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07280377
Title A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab (GOBLET)
Acronym GOBLET
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Oncolytics Biotech
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Nationales Centrum für Tumorerkrankungen Heidelberg Heidelberg Baden-Wurttemberg 69120 Germany Details
SLK-Kliniken Heilbronn GmbH Heilbronn Baden-Wurttemberg 74078 Germany Details
Universitätsklinikum Tübingen Tübingen Baden-Wurttemberg 72076 Germany Details
Universitätsklinikum Ulm Ulm Baden-Wurttemberg 89081 Germany Details
Gemeinschaftspraxis Dr. Med Bernhard Heinreich Augsburg Bavaria 86150 Germany Details
Klinikum der Universität München München Bavaria 81377 Germany Details
Hämatologisch-Onkologische Praxis Eppendorf Hamburg Free and Hanseatic City of Hamburg 20249 Germany Details
Asklepios Kliniken Hamburg GmbH Hamburg Free and Hanseatic City of Hamburg 22763 Germany Details
Krankenhaus Nordwest Frankfurt am Main Hesse 60488 Germany Details
St. Josef-Hospìtal, Bochum Bochum North Rhine-Westphalia 44791 Germany Details
Universitätsmedizin Mainz Mainz Rhineland-Palatinate 55131 Germany Details
Caritasklinikum Saarbrücken St. Theresia Saarbrücken Saarland 66113 Germany Details
Klinikum Chemnitz gGmbH Chemnitz Saxony 09116 Germany Details
Universität Leipzig Leipzig Saxony 04103 Germany Details
Charité Universitätsklinikum Berlin Berlin State of Berlin 13353 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field